Pharmacists' confidence in explaining biosimilars to patients before a nationwide medicine change: A cross-sectional study

BACKGROUND: Biosimilars can improve patient access to biological medicines. Although biosimilars have been shown to be equally effective and safe, some patients remain reluctant to transition to biosimilars. Pharmacists may support patients changing to biosimilars and are often at the frontline for...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasteiger, Chiara, Gasteiger, Norina, Petrie, Keith J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649382/
https://www.ncbi.nlm.nih.gov/pubmed/36386274
http://dx.doi.org/10.1016/j.rcsop.2022.100199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649382/
https://www.ncbi.nlm.nih.gov/pubmed/36386274
http://dx.doi.org/10.1016/j.rcsop.2022.100199

Ejemplares similares